Patent ID: 8716191
Filing Date: 2014-05-06
Classification: C12N,C12Q,C40B

Abstract:
1. A method of preparing an adduct as potential drug candidate or catalyst having a biological or catalytic activity for a target of interest, comprising: a) providing at least one library of PNA-encoded molecules and a library of nucleotide chains, b) hybridizing said at least one library of PNA-encoded molecules onto said library of nucleotide chains, c) bringing into contact the resulting library of PNA-encoded molecule(s)/nucleotide chain hybrid(s) with said target of interest, d) selecting the fittest PNA-encoded molecule(s)/nucleotide chain hybrid(s) for the target of interest, e) amplifying nucleotide chain(s) obtained from the previously mentioned fittest PNA-encoded molecule(s)/nucleotide chain hybrid(s), f) optionally bringing into contact said amplified nucleotide chain(s) with one or more library of PNA-encoded molecules, the library of PNA-encoded molecules having a content identical to that of said library(s) of PNA-encoded molecules provided in step a), or containing some modification, then hybridizing said amplified nucleotide chains(s) and said library of PNA-encoded molecules and repeating steps c) to e), step f) being repeated until a convergence towards one or several consensus sequences is obtained, g) identifying said nucleotide chain(s) obtained in step e) or f), each of said nucleotide chain(s) corresponding to at least one PNA-encoded molecule of the at least one library of PNA-encoded molecules recited in step a), h) determining at least one consensus structure provided by the nucleotide chain(s) identified in step g), said at least one consensus structure having a high-affinity to said target of interest, i) synthesizing a covalent adduct mimicking the consensus structure identified in step h), and j) validating the biological or catalytic activity of the covalent adduct.